Abstract

Transanal irrigation for intractable faecal incontinence and constipation: outcomes, quality of life and predicting non-adopters

Ng J1, Ford K, Dalton S, McDowell S, Charlesworth P, Cleeve S. Pediatr Surg Int. 2015 Jul 11. [Epub ahead of print]
 
     
Author information

1Department of Paediatric Surgery, The Royal London Hospital, London, UK, jessicaykng@outlook.com.

Abstract

PURPOSE: Intractable faecal incontinence (FI) and constipation is a challenging condition to manage in children. Transanal irrigation (TAI) is a non-operative treatment option. This study presents our experience with TAI with the aim of finding predictive factors of non-compliance.

METHODS: This is an outcome and quality of life (QoL) study of a prospectively maintained database of patients < 17 years old commenced on TAI for intractable FI/constipation between 2008 and 2014. Outcome measures were: (1) compliance-classified as non-adopter (use of TAI stopped within 1 month after commencement) or adopter; (2) functional outcome-classified as responder (totally continent or occasional soiling) or non-responder; (3) Rintala score; and (4) QoL score (PedsQL™ 4.0 Generic Core Scale). Analysis to determine predictive factors was also performed.

RESULTS: 42 patients were started on TAI [74 % male, median age of commencement was 7 (3-16) years]. Underlying diagnoses were: idiopathic constipation (62 %), anorectal malformation (26 %), Hirschsprung disease (5 %), spina bifida (5 %) and gastroschisis (2 %). Median follow-up period was 14 (3-78) months. 24 % were non-adopters. 84 % of the adopters responded to treatment. Rintala scores (mean ± SD) pre- and post-TAI were 6.7 ± 3.5 and 11.2 ± 4.8, respectively (P < 0.001). QoL scores pre- and post-TAI were 55.6 ± 24.1 and 65.5 ± 23.7, respectively (P < 0.001). Median age at which TAI was commenced in the non-adopter and adopter group were 6 (IQR 4.5-8.25) and 8 (IQR 7-12), respectively (P = 0.008).

CONCLUSION: TAI is a safe and effective treatment for intractable constipation/FI in children. If tolerated, it can significantly improve quality of life. Age and underlying diagnosis are important factors when recommending TAI to children with intractable FI/constipation.

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.